Product Information
VARENICLINE 1 MG CONT MONTH BX is a generic product labeled by Leading Pharma, LLC, priced at $0.4026 per EA under NDC 69315040358. Its NADAC has been published 131 times since Dec 13, 2023.
Strength
1 mg/561
Manufacturer
Leading Pharma, LLCNDC
69315040358
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
5/20/2026
Active Ingredients
VARENICLINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA217151On Market Since
10/1/2023
Pharmacological Classes
Price Statistics
The NADAC for VARENICLINE 1 MG CONT MONTH BX has been published 131 times since Dec 13, 2023, and over the history we have for it it has declined 91.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4026 per EA |
|---|---|
| All-time high | $4.4794 (Dec 13, 2023) |
| All-time low | $0.4026 (May 20, 2026) |
| 52-week high | $0.5408 |
| 52-week low | $0.4026 |
| Median price | $0.5844 |
| Average price | $0.9725 |
| Largest weekly change | -51.0% (Nov 20, 2024) |
| Weeks tracked | 131 |
| Tracking since | Dec 13, 2023 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VARENICLINE 1 MG CONT MONTH BX?
The current National Average Drug Acquisition Cost (NADAC) for VARENICLINE 1 MG CONT MONTH BX, manufactured by Leading Pharma, LLC, is $0.4026 per EA (NDC 69315040358), effective Jun 10, 2026.
How has the price of VARENICLINE 1 MG CONT MONTH BX changed over time?
Over the history we have for it, the NADAC for VARENICLINE 1 MG CONT MONTH BX has declined 91.0%. It has been tracked across 131 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for VARENICLINE 1 MG CONT MONTH BX?
Since Dec 13, 2023, the NADAC for VARENICLINE 1 MG CONT MONTH BX has ranged from a low of $0.4026 (May 20, 2026) to a high of $4.4794 (Dec 13, 2023), with a median of $0.5844 per EA.
Are there cheaper alternatives to VARENICLINE 1 MG CONT MONTH BX?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as VARENICLINE 1 MG CONT MONTH BX, but none are currently priced below it.
Who manufactures VARENICLINE 1 MG CONT MONTH BX?
VARENICLINE 1 MG CONT MONTH BX (NDC 69315040358) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification